Melinta Therapeutics Presents at Clinical Microbiology & Infectious Diseases Congress

Viewing 3 posts - 1 through 3 (of 3 total)
  • Author
    Posts
  • #20524
    ClemSnide
    Participant

    Melinta Therapeutics focusing on the development and commercialization…

    [article]1461[/article]

    #20970
    ClemSnide
    Participant

    Melinta Therapeutics Inc Falls 10.22% After JP Morgan downgraded MLNT

    Downgraded from Neutral to Underweight. Melinta Therapeutics shares had risen2.2% to close at $1.86 on Thursday.

    #22236
    TradersCom
    Keymaster

    [size=5][b]Pdufa dates arrive this week
    [/b][/size]
    GlaxoSmithKline’s (NYSE:GSK) Zejula and Melinta Therapeutics (NASDAQ:MLNT)-Ligand Pharmaceuticals’ (NASDAQ:LGND) Baxdela sNDA.

Viewing 3 posts - 1 through 3 (of 3 total)
  • You must be logged in to reply to this topic.